“No questions” letter from US Food and Drug Administration signals support for the safety of the Oubli Fruit Sweet Protein for use in food and beverages DAVIS, Calif., March 20, 2024 /PRNewswire/ — Oobli, the leading global sweet protein platform known for its healthy sugar alternatives,…
Oobli Becomes First Company to Receive FDA “No Questions” Letter for a Novel Sweet Protein Produced via Precision Fermentation
This post was originally published on this site